10/08/2026
2026 International Biospecimen Summit PROGRAM HIGHLIGHT 💡Workshop 2: Accelerating Biotech Access to Biobanks: From Sample Sourcing to Pilot Validation and Fundraising Readiness
🎤 Featuring: Heidi Wagner, Riley Cox, Terence O'Keeffe, Kenneth To, Robby Spring, Mathew Platt
Startups developing diagnostics, biomarkers, AI tools, therapeutics, digital pathology platforms, and precision oncology technologies often require access to high-quality biospecimens and associated clinical data to generate early validation evidence. However, sourcing biobank samples can be difficult to navigate, particularly when companies are balancing scientific validation, fundraising timelines, investor diligence, and biobank regulatory and legal requirements. At the same time, biobanks and research institutions need responsible access models.
This workshop will position biobanks as critical translational research infrastructure and explore how responsible, transparent, and governance-aligned access pathways can help biotech startups generate credible validation evidence using high-quality biospecimens and linked clinical data.
📋 REVIEW THE PROGRAM AND REGISTER TODAY!
👉 www.isber.org/2026BiospecimenSummit